iShares Biotechnology ETF
666 hedge funds and large institutions have $5.08B invested in iShares Biotechnology ETF in 2020 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 176 increasing their positions, 252 reducing their positions, and 116 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
666
Holders Change
-44
Holders Change %
-6.2%
% of All Funds
14.71%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.31%
New
80
Increased
176
Reduced
252
Closed
116
Calls
$359M
Puts
$729M
Net Calls
-$370M
Net Calls Change
+$154M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$133M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$36.3M |
| 3 |
Morgan Stanley
New York
|
+$35.3M |
| 4 |
JG
Jefferies Group
New York
|
+$18M |
| 5 |
CB
Commerce Bank
Kansas City,
Missouri
|
+$15M |
Top Sellers
| 1 |
Citigroup
New York
|
-$330M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$135M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$112M |
| 4 |
Two Sigma Investments
New York
|
-$77.2M |
| 5 |
Two Sigma Advisers
New York
|
-$51.5M |
